DOI:
10.1055/s-00029028
Journal of Pediatric Infectious Diseases
LinksClose Window
References
Dooley KE, Bliven-Sizemore EE, Weiner M. , et al.
Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers.
Clin Pharmacol Ther 2012;
91 (05) 881-888
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.